materiaux

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers. Led by Co-director Ralph Weichselbaum, investigator Wenbin Lin and postdoctoral researcher Kaiting Yang at the Ludwig Center at Chicago, the study describes the synthesis, mechanism of action and preclinical assessment of the nanoparticle, which is loaded with a drug that activates a protein central to the efficient induction of anti-cancer immunity.

Researchers at Johannes Gutenberg University Mainz (JGU) are pursuing a completely new and unconventional strategy to improve the way data can be processed and – in particular – stored. Together with their partners at the Hebrew University of Jerusalem, they have been granted funding by the Carl Zeiss Foundation (CZS). The project of this interdisciplinary team is among a total of five projects – all at early stages and considered to be especially innovative – to be funded through the new CZS Wildcard program. The team members, based in Mainz and Jerusalem, have come up with the idea of bringing together two different forms of chirality to develop new data storage systems that are faster, smaller, and more efficient than those currently available.